Missouri Access Score: 10/100
Composite of methadone OTP density, buprenorphine provider density, mental health shortage need-met %, Medicaid coverage breadth, 1115 SUD waiver status, and legal protections. How we score.
Missouri has 276 active NPPES enumerations across 12 cities for clinicians who commonly prescribe buprenorphine for opioid use disorder. Coverage is wider than the old X-waiver lists suggested, but availability still varies clinic to clinic. Confirm intake before you drive anywhere.
Composite analysis
Missouri sits in the top quarter of states for treatment access pressure. Demand signals are elevated and verified provider supply is thin relative to population.
TAPI is a CCIWA composite. Each input is z-scored across 50 states plus DC and Puerto Rico, then combined as a weighted sum (HPSA 30%, frequent mental distress 25%, unemployment 15%, treatment density 30%, sign-flipped). The result is rescaled 0 to 100 by percentile rank. Read the full methodology.
Composite of methadone OTP density, buprenorphine provider density, mental health shortage need-met %, Medicaid coverage breadth, 1115 SUD waiver status, and legal protections. How we score.
| Component | Detail | Points |
|---|---|---|
| OTP density | Unknown | 0 / 30 |
| Buprenorphine density | Unknown | 0 / 20 |
| Mental health HPSA need met | Unknown | 10 / 20 |
| Medicaid breadth | 0 of 5 service categories covered | 0 / 15 |
| 1115 SUD waiver | None | 0 / 10 |
| Legal protections | Good Samaritan: No · Naloxone access: No | 0 / 5 |
Cities below have at least 5 active prescribers. Smaller cities consolidate into the closest hub city for V1.